Last week a literature review showed none of 62 high-quality medical AI models ready for translation from academic research to clinical practice. Now comes a similar but separate study confirming the depth of the dashed hopes.

The FDA has granted 510(k) clearance to clinical decision support software that uses AI to detect small but potentially cancerous lesions in the lungs.

Last spring the COVID-19 pandemic flipped daily life on its head, disrupting every sector of the economy. A year later, healthcare leaders are still reckoning with the accelerated evolution brought on by the pandemic’s unprecedented economic demands.

The FDA has blessed an AI-packing armband that checks for biometric patterns pointing to possible SARS-CoV-2 infection in individuals with no symptoms.

The European Union has granted CE mark approval to a U.S.-based maker of AI software that aids radiologists in distinguishing between benign and malignant lesions on breast ultrasound images.

Health insurance giant Humana has rebranded its payer-agnostic healthcare services business, including its Partners in Primary Care and Family Physicians Group, to CenterWell.

Rosalind Brewer has officially taken over as CEO of Walgreens Boots Alliance as of March 15.

The FDA has greenlit an AI algorithm that automatically measures dilation in the heart’s right ventricle on CT images.